This free eBook showcases some of our top content covering outsourcing and supply chains.

A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?

We all know that automation can reduce human labor, but how else can it make economically viable cell and gene therapies a reality?

Genetic insights may offer shortcuts along the clinical development pathway, bringing new therapeutics to market faster

Demand for cell and gene therapies is increasing, but are current manufacturing approaches up to the task?

CEO and Founder of EnteroBiotix James McIllroy shares the wonders of manipulating our microbial passengers.

Though key hurdles remain, there is huge potential for mRNA-based therapeutics to tackle areas of unmet need.

Water is the giver of life, but could it be a giver of untold medicines too?

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

BASF has put substantial effort into reducing carbon emissions. A key aspect of their strategy lies in extracting and acting upon the right data.